Jerome I Rotter Selected Research

Insulin Resistance

7/2022	Cesarean Delivery and Insulin Sensitivity in the Older Adult: The Microbiome and Insulin Longitudinal Evaluation Study.
1/2022	Associations between adherence to the dietary approaches to stop hypertension (DASH) diet and six glucose homeostasis traits in the Microbiome and Insulin Longitudinal Evaluation Study (MILES).
6/2021	Defining the Relative Role of Insulin Clearance in Early Dysglycemia in Relation to Insulin Sensitivity and Insulin Secretion: The Microbiome and Insulin Longitudinal Evaluation Study (MILES).
1/2021	Multi-omics analysis identifies CpGs near G6PC2 mediating the effects of genetic variants on fasting glucose.
11/2020	Rationale, design and baseline characteristics of the Microbiome and Insulin Longitudinal Evaluation Study (MILES).
8/2020	Physical Activity Associations with Bone Mineral Density and Modification by Metabolic Traits.
1/2020	Classification of Type 2 Diabetes Genetic Variants and a Novel Genetic Risk Score Association With Insulin Clearance.
7/2019	Insulin Resistance Exacerbates Genetic Predisposition to Nonalcoholic Fatty Liver Disease in Individuals Without Diabetes.
1/2019	Adiposity-Independent Effects of Aging on Insulin Sensitivity and Clearance in Mice and Humans.
1/2019	The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance, β-cell function, and diabetes in Hispanics and African Americans.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jerome I Rotter Research Topics

Disease

66	Insulin Resistance 07/2022 - 05/2002
52	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2004
49	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2002
48	Atherosclerosis 01/2022 - 08/2003
24	Obesity 01/2022 - 05/2002
23	Hypertension (High Blood Pressure) 01/2022 - 02/2002
20	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 07/2003
19	Inflammation (Inflammations) 01/2022 - 01/2008
19	Crohn Disease (Crohn's Disease) 11/2018 - 02/2004
16	Coronary Disease (Coronary Heart Disease) 01/2022 - 04/2003
11	Stroke (Strokes) 01/2022 - 09/2013
10	Ulcerative Colitis 06/2012 - 05/2007
9	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2020 - 02/2002
8	Myocardial Infarction 01/2022 - 01/2012
8	Atrial Fibrillation 12/2021 - 02/2010
7	Genetic Risk Score 01/2020 - 02/2014
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 04/2004
6	Chronic Obstructive Pulmonary Disease (COPD) 11/2022 - 04/2014
6	Heart Failure 01/2022 - 02/2013
6	Non-alcoholic Fatty Liver Disease 01/2022 - 11/2010
6	Keratoconus 01/2021 - 10/2011
6	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2017
6	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019 - 10/2009
5	Cardiac Sudden Death (Sudden Cardiac Arrest) 11/2019 - 04/2009
5	Macular Degeneration (Age-Related Maculopathy) 12/2017 - 01/2013
5	Neoplasms (Cancer) 10/2016 - 03/2011
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016 - 09/2002
4	Apnea 11/2022 - 01/2019
4	Abdominal Obesity 04/2012 - 07/2007
3	Prediabetic State (Prediabetes) 07/2022 - 07/2010
3	Emphysema 01/2022 - 04/2014
3	Hypoxia (Hypoxemia) 01/2022 - 11/2017
3	Breast Neoplasms (Breast Cancer) 12/2021 - 07/2012
3	Sleep Apnea Syndromes (Sleep Apnea) 11/2021 - 11/2019
3	Dyslipidemias (Dyslipidemia) 01/2021 - 10/2011
3	Metabolic Diseases (Metabolic Disease) 12/2019 - 07/2007
3	Hyperglycemia 01/2019 - 01/2017
3	Disease Progression 01/2017 - 02/2006

Drug/Important Bio-Agent (IBA)

58	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 05/2002
46	Insulin (Novolin)FDA Link 07/2022 - 05/2002
36	LipidsIBA 01/2022 - 05/2002
26	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2007
23	LDL CholesterolIBA 01/2022 - 03/2006
19	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2002
17	oxidized low density lipoproteinIBA 01/2022 - 03/2006
17	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 03/2008
16	HDL CholesterolIBA 01/2022 - 04/2004
16	Triglycerides (Triacylglycerol)IBA 12/2021 - 03/2006
13	AdiponectinIBA 08/2020 - 06/2006
12	Biological ProductsIBA 01/2022 - 04/2008
11	CholesterolIBA 01/2021 - 03/2010
10	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2004
10	CalciumIBA 01/2022 - 12/2010
10	Pharmaceutical PreparationsIBA 12/2021 - 11/2004
8	C-Reactive ProteinIBA 08/2020 - 07/2007
7	AntigensIBA 08/2010 - 02/2002
6	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2013
6	AntibodiesIBA 01/2019 - 02/2004
6	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2018 - 07/2003
6	Genetic Markers (Genetic Marker)IBA 12/2017 - 06/2004
5	Vitamin D FDA LinkGeneric 01/2022 - 08/2017
5	Mitochondrial DNA (mtDNA)IBA 10/2021 - 11/2017
5	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 10/2013
5	Retinaldehyde (Retinal)IBA 09/2018 - 10/2010
5	Lipoproteins (Lipoprotein)IBA 12/2017 - 08/2009
5	P-2 (P 2)IBA 08/2017 - 02/2014
5	Blood Glucose (Blood Sugar)IBA 04/2015 - 05/2008
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 03/2014
4	EnzymesIBA 01/2022 - 01/2019
4	Insulin-Like Growth Factor I (IGF-1)IBA 12/2021 - 03/2011
4	Oxyhemoglobins (Oxyhemoglobin)IBA 01/2021 - 01/2019
4	Hemoglobins (Hemoglobin)IBA 01/2019 - 04/2015
4	HDL LipoproteinsIBA 01/2018 - 05/2012
4	Simvastatin (Zocor)FDA LinkGeneric 01/2017 - 03/2006
4	AdipokinesIBA 12/2013 - 01/2013
4	Interleukin-23 (Interleukin 23)IBA 09/2012 - 12/2006
3	Alanine Transaminase (SGPT)IBA 01/2022 - 01/2021
3	NucleotidesIBA 01/2022 - 09/2002
3	Insulin-Like PeptidesIBA 12/2021 - 01/2016
3	Lipoprotein(a)IBA 01/2021 - 05/2012
3	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2019
3	CatecholaminesIBA 12/2019 - 12/2010
3	Fibrinogen (Factor I)FDA Link 12/2019 - 09/2013
3	AlbuminsIBA 11/2019 - 06/2005
3	CreatinineIBA 11/2019 - 06/2005
3	von Willebrand FactorIBA 01/2019 - 03/2010
3	Carrier Proteins (Binding Protein)IBA 01/2019 - 01/2017
3	Hormones (Hormone)IBA 01/2019 - 01/2012
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2019 - 09/2013
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2017 - 02/2002
3	AcetyltransferasesIBA 01/2017 - 04/2015
3	Complement Factor H (Factor H)IBA 01/2016 - 01/2013
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2016 - 02/2004
3	CytokinesIBA 11/2015 - 12/2006
3	Antihypertensive Agents (Antihypertensives)IBA 01/2015 - 11/2010
3	ApolipoproteinsIBA 01/2013 - 05/2002
3	PorinsIBA 02/2007 - 02/2004

Therapy/Procedure

17	Therapeutics 01/2021 - 07/2004
10	Precision Medicine 11/2022 - 10/2020
4	Glycemic Control 01/2021 - 09/2017